Search

Your search keyword '"Alberto"' showing total 5,872 results

Search Constraints

Start Over You searched for: Author "Alberto" Remove constraint Author: "Alberto" Journal blood Remove constraint Journal: blood
5,872 results on '"Alberto"'

Search Results

1. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

2. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey

3. KDM6A regulates immune response genes in multiple myeloma

4. NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome

6. Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma

7. A new severe congenital neutropenia syndrome associated with autosomal recessive COPZ1 mutations

9. Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study

11. Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients

12. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

13. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

15. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

16. Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study

17. CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies

18. Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients

20. Genetic and phenotypic attributes of splenic marginal zone lymphoma

23. Clinical relevance of clonal hematopoiesis in persons aged ≥80 years

24. COVID-19 in patients with CLL: improved survival outcomes and update on management strategies

28. Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome

29. Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma

30. Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma

31. A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

32. Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma

33. Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier

35. Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma

36. Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study

38. Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib

39. Interleukin-1 blockade in patients with Wiskott-Aldrich syndrome: a retrospective multinational case series

41. Mutually-Exclusive Pathways between IKZF1 plus and RAS Mutations and TP53 double-Hit Alterations Lead Relapse in B-Other, Ph-like and Hyperdiploidy Genetic Groups in Adult B-Cell Acute Lymphoblastic Leukemia

42. Activating NSD2 Mutations Drive Oncogenic Reprogramming By Disturbing Epigenetic Landscape in Mantle Cell Lymphoma

43. Safety Profile in Patients with Chronic Lymphocytic Leukemia Undergoing Treatment with 1st and 2nd Generation Bruton Tyrosine Kinase Inhibitors: Multicentric Real-World Experience

44. TRAF3-Inactivated Chronic Lymphocytic Leukemia Cells Show an Enhanced Metabolic Plasticity That Can be Attenuated By Glutaminolysis and Mitochondrial Pyruvate Import Inhibition

45. Chronic Obstructive Pulmonary Disease and Previous Infections Have Impact on Infectious Complications in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Multicentre Seifem Study

46. Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL

47. Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)

48. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

49. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

50. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study

Catalog

Books, media, physical & digital resources